Advanced search
Publication Cover
Pediatric Health Volume 1, 2007 - Issue 1
Journal homepage
81
Views
0
CrossRef citations to date
0
Altmetric
Review

Antibiotic Therapy for Pneumonia in the Pediatric Population

Matti KorppiTampere University and University Hospital, Paediatric Research Centre, 33014, Finland Tel.: +358 335 518 407; Fax.: +358 335 518 420; Email:[email protected]View further author information
Pages 77-85 | Published online: 16 Oct 2007

Bibliography

  • British Thoracic Society: BTS guidelines for the management of community-acquired pneumonia in childhood. Thorax57, i1–i24 (2002).
  • McIntosh K : Community-acquired pneumonia in children.N. Engl. J. Med.346, 429–437(2002).
  • Korppi M : Community-acquired pneumonia in children: issues in optimizing antibacterial treatment.Pediatr. Drugs5, 821–832(2003).
  • Sazawal S , BlockR: Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials.Lancet Infect. Dis.3, 547–356(2003).
  • Murphy TF , HendersonFW, ClydeWA Jr et al.: Pneumonia: an eleven-year study in a pediatric practice. Am. J. Epidemiol.113, 12–21(1981).
  • Heiskanen-Kosma T , KorppiM, JokinenCet al.: Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr. Infect. Dis. J.17, 986–991(1998).
  • Don M , FasoliL, PaldaniusMet al.: Aetiology of community-acquired pneumonia: serological results of a paediatric survey. Scand. J. Infect. Dis.3, 806–812(2005).
  • Nohynek H , EskolaJ, KleemolaM, Jalonen E, Saikku P, Leinonen M: Bacterial antibody assays in the diagnosis of acute lower respiratory tract infection in children. Pediatr. Infect. Dis. J.14, 478–484(1995).
  • Korppi M , LeinonenM: Pneumococcal immune complexes in the diagnosis of lower respiratory tract infections in children.Pediatr. Infect. Dis. J.8, 687–692(1998).
  • Korppi M : Mixed microbial aetiology of community-acquired pneumonia in children.APMIS110, 515–522(2002).
  • Korppi M , Heiskanen-KosmaT, Kleemola M: Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective population-based study in primary health care. Respirology9, 109–114(2004).
  • Esposito S , BlasiF, BelliniFet al.: Mycoplasma pneumonie and Chlamydia pneumoniae infections in children with pneumonia. Eur. Respir. J.17, 241–245(2001).
  • Heiskanen-Kosma T , KorppiM, Leinonen M: Serologically indicated pneumonococcal pneumonia in children: a population-based study in primary care settings. APMIS111, 945–950(2003).
  • Michelow I , LozanoJ, OlsenKet al.: Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serologic testing, and urinary antigen detection. Clin. Infect. Dis.34, e1–e11 (2002).
  • Michelow IC , OlsenK, LozanoJet al.: Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics113, 701–707(2004).
  • Mulholland EK , SimoesEA, CostalesMO, McGrathEJ, ManalcEM, GoveS: Standardized diagnosis of pneumonia in developing countries.Pediatr. Infect. Dis. J.11, 77–81(1992).
  • Palafox M , GuisfreH, ReyesH, MunozO, MartinezH: Diagnostic value of tachypnoea in pneumonia defined radiologically.Arch. Dis. Child.82, 41–45(2000).
  • Hazir T , NisarYB, QaziSAet al.: Chest radiography in children aged 2–59 months diagnosed with non-severe pneumonia as defined by World Health Organization: descriptive multicentre study in Pakistan. Brit. Med. J.333(7569), 629 (2006).
  • Esposito S , BosisS, CavagnaRet al.: Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2–5 years of age with community-acquired pneumonia. Clin. Infect. Dis.35, 1345–1352(2002).
  • Juven T , RuuskanenO, MertsolaJ: Symptoms and signs of community-acquired pneumonia in children.Scand. J. Prim. Health Care21, 52–56(2003).
  • Clements H , StephenssonT, GabrielVet al.: Rationalised prescribing for community-acquired pneumonia: a closed loop audit. Arch. Dis. Child.83, 320–324(2000).
  • Virkki R , JuvenT, RikalainenH, Svedström E, Mertsola J, Ruuskanen O: Differentiation of bacterial and viral pneumonia in children. Thorax57, 438–441(2002).
  • Lynch T , GouinS, LarsonC, PatenaudeY: Does lateral chest radiograph help pediatric emergency physicians diagnose pneumonia? A randomized controlled trial.Acad. Emerg. Med.11, 625–629(2004).
  • Jaye DL , WaitesKB: Clinical applications of C-reactive protein in pediatrics.Pediatr. Infect. Dis. J.18, 735–746(1997).
  • Toikka P , IrjalaK, JuvenTet al.: Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr. Infect. Dis. J.19, 598–602(2000).
  • Gendrel D , BohuonC: Procalcitonin as a marker of bacterial infection.Pediatr. Infect. Dis. J.19, 679–687(2000).
  • Don M , ValentF, KorppiMet al.: Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood. Scand. J. Infect. Dis.39, 129–137(2007).
  • Korppi M : Non-specific host response markers in the differentiation between pneumococcal and viral pneumonia: what is the best combination?Pediatr. Int.46, 545–550(2004).
  • Heiskanen-Kosma T , KorppiM: Serum C-reactive protein cannot differentiate bacterial and viral aetiology of community-acquired pneumonia in children in primary health care settings.Scand. J. Infect. Dis.32, 399–402(2000).
  • Korppi M , RemesS, Heiskanen-KosmaT: Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary health care settings.Pediatr. Pulmonol.35, 56–61(2003).
  • Kabra SK , LodhaR, PandeyRM: Antibiotics for community acquired pneumonia in children.Cochrane Database of Syst. Rev.3, CD004874 (2006).
  • Esposito S , BlasiF, ArosioCet al.: Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur. Respir. J.16, 1142–1146(2000).
  • Korppi M , HiltunenJ: Pertussis is common in nonvaccinated infants hospitalized for respiratory syncytial virus infection.Pediatr. Infect. Dis. J.26, 316–319(2007).
  • Jacobs MR : Worldwide trends in antimicrobial resistance among common respiratory pathogens in children.Pediatr. Infect. Dis. J.22(Suppl.), 109–119(2003).
  • Vuori-Holopainen E , PeltolaH, KallioMet al.: Narrow- versus broad-spectrum parenteral antimicrobials against common infections of childhood: a prospective and randomized comparison between penicillin and cefuroxime. Eur. J. Pediatr.159, 878–884(2000).
  • Little P , RumsbyK, KellyJet al.: Information leaflet and antibiotic prescribing strategies foracute lower respiatory tract infection. JAMA293, 3029–3035(2005).
  • Juven T , MertsolaJ, WarisM, LeinonenM, RuuskanenO: Clinical response to antibiotic therapy for community-acquired pneumonia.Eur. J. Pediatr.163, 140–144(2004).
  • Addo-Yobo E , ChisakaN, HassanMet al.: APPIS group. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomized multicentre equivalency study. Lancet364, 1141–1148(2004).
  • Hazir T , QaziSA, NisarYBet al.: Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2–59 months: a multicentre, double-blind, randomized controlled trial in Pakistan. Arch. Dis. Child.92, 291–297(2007).
  • Schito GC , MarcheseA, ElkharratD, Farrell DJ: Comparative activity of telithormycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PROTEKT surveillance study. J. Chemother.16, 13–22(2004).
  • Volonakis K , SouliM, KapaskelisAet al.: Evolution of resistance patterns and identification of risk factors for streptococcus pneumonia colonization in daycare centre attendees in Athens, Greece. Int. J. Antimicrob. Agents28, 297–301(2006).
  • Inoue M , KanekoK, AkizawaKet al.: Antimicrobials susceptibility of respiratory tract pathogens in Japan during PROTEKT years 1999–2002. J. Infect. Chemother.12, 9–21(2006).
  • Agraval G , AwasthiS, KabraSKet al.: ISCAP study group. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomized controlled trial. Brit. Med. J.328, 791–794(2004).
  • Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia Study Group: Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet360, 835–841(2002).
  • Virkki R , JuvenT, MertsolaJ, Ruuskanen O: Radiographic follow-up of pneumonia in children Pediatr. Pulmonol.40, 223–227(2005).
  • Byington CL , SpencerLY, JohnsonTAet al.: An epidemiological investigation of sustained high rate of pediatric empyema: risk factors and microbiological associations. Clin. Infect. Dis.34, 434–440(2002).
  • Byington CL , KorgenskiK, DakyJet al.: Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr. Infect. Dis. J.24, 250–254(2006).
  • Hacimustafaoglu M , CelebiS, Sarimehmet H, Gurpinar A, Ercan I: Necrotizing pneumonia in children. Acta Paediatr.93, 1172–1177(2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.